Weekly Investment Analysts’ Ratings Changes for Celldex Therapeutics (CLDX)
Several analysts have recently updated their ratings and price targets for Celldex Therapeutics (NASDAQ: CLDX): 5/9/2025 – Celldex Therapeutics had its price target lowered by analysts at Morgan Stanley from $46.00 to $43.00. They now have an “overweight” rating on the stock. 5/9/2025 – Celldex Therapeutics had its price target lowered by analysts at The […]
Several analysts have recently updated their ratings and price targets for Celldex Therapeutics (NASDAQ: CLDX): 5/9/2025 – Celldex Therapeutics had its price target lowered by analysts at Morgan Stanley from $46.00 to $43.00. They now have an “overweight” rating on the stock. 5/9/2025 – Celldex Therapeutics had its price target lowered by analysts at The […]
